Prevnar 20

— THERAPEUTIC DISORDERS TREATED —
  • Vaccines

Prevnar 20 Generic Name & Formulations

General Description

Pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) 46.2micrograms of saccharides per 0.5mL; susp for IM inj; contains aluminum.

Pharmacological Class

PCV.

How Supplied

Prefilled syringes—1, 10

Manufacturer

Generic Availability

NO

Prevnar 20 Indications

Indications

Active immunization against pneumonia and invasive disease caused by S. pneumoniae due to serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F.

Prevnar 20 Dosage and Administration

Adult

≥18yrs: 0.5mg IM once.

Children

<18yrs: not established.

Prevnar 20 Contraindications

Contraindications

Allergies to any diphtheria toxoid-containing vaccine.

Prevnar 20 Boxed Warnings

Not Applicable

Prevnar 20 Warnings/Precautions

Warnings/Precautions

Have epinephrine inj available. Immunocompromised. Pregnancy. Nursing mothers.

Prevnar 20 Pharmacokinetics

See Literature

Prevnar 20 Interactions

Interactions

Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response. Antibody responses may be diminished if Pneumovax 23 was received 1 to 5 years prior to Prevnar 20.

Prevnar 20 Adverse Reactions

Adverse Reactions

Inj site reactions (eg, pain, swelling), muscle pain, fatigue, headache, arthralgia.

Prevnar 20 Clinical Trials

See Literature

Prevnar 20 Note

Not Applicable

Prevnar 20 Patient Counseling

See Literature